Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
Authors:
- Diana FerraroDFDiana Ferraro
- Roberta BedinRBRoberta Bedin
- Patrizia NataliPNPatrizia Natali
- Diego FranciottaDFDiego Franciotta
- Krzysztof SmolikKSKrzysztof Smolik
- Mario SantangeloMSMario Santangelo
- Paolo ImmovilliPIPaolo Immovilli
- Valentina CameraVCValentina Camera
- Francesca VitettaFVFrancesca Vitetta
- Matteo GastaldiMGMatteo Gastaldi
- Tommaso TrentiTTTommaso Trenti
- Stefano MelettiSMStefano Meletti
Open Access
- 21 October 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (10) , 856
Abstract
Background: Cerebrospinal fluid (CSF) kappa free light chains (KFLC) are gaining increasing interest as markers of intrathecal immunoglobulin synthesis. The main aim of this study was to assess the diagnostic accuracy (AUC) of the kappa index (CSF/serum KFLC divided by the CSF/serum albumin ratio) compared to CSF oligoclonal IgG bands (OCB) in predicting Multiple Sclerosis (MS) or a central nervous system infectious/inflammatory disorder (CNSID). Methods: We enrolled patients who underwent a diagnostic spinal tap throughout two years. KFLC levels were determined using a Freelite assay (Binding Site) and the turbidimetric Optilite analyzer. Results: Of 540 included patients, 223 had a CNSID, and 84 had MS. The kappa index was more sensitive (0.89 versus 0.85) and less specific (0.84 versus 0.89), with the same AUC (0.87) as OCB for MS diagnosis (optimal cut-off: 6.2). Adding patients with a single CSF IgG band to the OCB-positive group slightly increased the AUC (0.88). Likewise, the kappa index (cut-off: 3.9) was more sensitive (0.67 versus 0.50) and less specific (0.81 versus 0.97), with the same AUC (0.74) as OCB, for a CNSID diagnosis. Conclusion: The kappa index and CSF OCB have comparable diagnostic accuracies for a MS or CNSID diagnosis and supply the clinician with useful, complementary information.Keywords
This publication has 31 references indexed in Scilit:
- Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosisJournal of Neuroimmunology, 2020
- Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band‐negative patients with suspected multiple sclerosisEuropean Journal of Neurology, 2019
- Diagnostic relevance of free light chains in cerebrospinal fluid – The hyperbolic reference range for reliable data interpretation in quotient diagramsClinica Chimica Acta, 2019
- Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing–remitting multiple sclerosisEuropean Journal of Neurology, 2018
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaThe Lancet Neurology, 2018
- An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosisExpert Review of Molecular Diagnostics, 2016
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesisJournal of Neuroimmunology, 2013
- Free immunoglobulin light chain: Its biology and implications in diseasesClinica Chimica Acta, 2011
- Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosisJournal of Neurology, 2008